Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Cristofanilli

Showing results (141-150 of 438) with videos related to

Pageof 44
Sort By:
Cancer|April 30, 2019
Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platformsBetina Yanez, Laura C Bouchard, David Cella, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Circulating tumor cells <i>et al.</i>: towards a comprehensive liquid biopsy approach in breast cancerEleonora Nicolò, Caterina Gianni, Letizia Pontolillo, et al.
AJR. American Journal of Roentgenology|September 24, 2011
MRI features of inflammatory breast cancerHuong T Le-Petross, Massimo Cristofanilli, Selin Carkaci, et al.
Cancer|June 30, 2011
Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcomeYun Gong, Lei Huo, Ping Liu, et al.
International Journal of Clinical Oncology|June 15, 2011
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancerNaoki Hayashi, Seigo Nakamura, Yasuharu Tokuda, et al.
Ebiomedicine|May 19, 2019
A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapyZhuan Zhou, Zhiwei Feng, Dong Hu, et al.
Cancer|April 22, 2011
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based studyShaheenah Dawood, Naoto T Ueno, Vicente Valero, et al.
Breast Cancer Research : BCR|March 25, 2016
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cellsIsraa Salem, Manal Alsalahi, Inna Chervoneva, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast ConditionsDaniel L Adams, Diane K Adams, R Katherine Alpaugh, et al.
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Pageof 44

Showing results (141-150 of 438) with videos related to

Sort By:
Pageof 44
Cancer|April 30, 2019
Patient-centered engagement and symptom/toxicity monitoring in the new era of tumor next-generation sequencing and immunotherapy: The OncoTool and OncoPRO platformsBetina Yanez, Laura C Bouchard, David Cella, et al.
Translational Breast Cancer Research : a Journal Focusing on Translational Research in Breast Cancer|May 16, 2024
Circulating tumor cells <i>et al.</i>: towards a comprehensive liquid biopsy approach in breast cancerEleonora Nicolò, Caterina Gianni, Letizia Pontolillo, et al.
AJR. American Journal of Roentgenology|September 24, 2011
MRI features of inflammatory breast cancerHuong T Le-Petross, Massimo Cristofanilli, Selin Carkaci, et al.
Cancer|June 30, 2011
Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcomeYun Gong, Lei Huo, Ping Liu, et al.
International Journal of Clinical Oncology|June 15, 2011
Prognostic value of HER2-positive circulating tumor cells in patients with metastatic breast cancerNaoki Hayashi, Seigo Nakamura, Yasuharu Tokuda, et al.
Ebiomedicine|May 19, 2019
A novel small-molecule antagonizes PRMT5-mediated KLF4 methylation for targeted therapyZhuan Zhou, Zhiwei Feng, Dong Hu, et al.
Cancer|April 22, 2011
Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based studyShaheenah Dawood, Naoto T Ueno, Vicente Valero, et al.
Breast Cancer Research : BCR|March 25, 2016
The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cellsIsraa Salem, Manal Alsalahi, Inna Chervoneva, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 20, 2016
Circulating Cancer-Associated Macrophage-Like Cells Differentiate Malignant Breast Cancer and Benign Breast ConditionsDaniel L Adams, Diane K Adams, R Katherine Alpaugh, et al.
Oncotarget|December 8, 2016
Developmental therapeutics for inflammatory breast cancer: Biology and translational directionsRicardo Costa, Cesar A Santa-Maria, Giovanna Rossi, et al.
Pageof 44